Want to see IN:ADVENZYMES full AI Analyst Report?
ADVENZYMES Stock Chart & Stats
₹303.25
-₹1.10(-0.32%)
At close: 4:00 PM EST
₹303.25
-₹1.10(-0.32%)
Day’s Range― - ―
52-Week Range₹251.90 - ₹419.80
Previous CloseN/A
Volume535.87K
Average Volume (3M)17.03K
Market Cap
₹33.01B
Enterprise Value₹22.36K
Total Cash (Recent Filing)₹7.05B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)19.8
Beta1.15
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.46%
Share Statistics
EPS (TTM)14.82
Shares Outstanding111,976,150
10 Day Avg. Volume11,571
30 Day Avg. Volume17,030
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)1.75
Price to Sales (P/S)3.83
P/FCF Ratio23.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)15.5
Revenue Forecast (FY)₹8.54B
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage and debt-to-equity around 0.01–0.04 gives ample financial flexibility and low solvency risk. Structurally this enables sustained investment in R&D, manufacturing scale-up and customer qualification without relying on external funding, supporting resilience over cycles.
Strong Cash GenerationOperating cash flow consistently exceeding net income indicates high earnings quality and durable internal funding for capex, product development and working capital. This reduces dependence on external debt and supports consistent reinvestment and strategic initiatives over the medium term.
Diversified End-Markets & ManufacturingBroad B2B exposure across human nutrition, animal feed, food processing and industrial applications plus in-house fermentation gives demand diversification and cost/control advantages. Repeat qualification in customer processes creates sticky revenue and makes growth less dependent on a single sector.
Bears Say
Margin CompressionNet and operating margins have meaningfully compressed from peak levels, implying structural pressure from pricing, mix shifts or higher input costs. Sustained margin normalization constrains the company’s ability to expand profitability and reduces excess cash available for growth initiatives.
Free Cash Flow VolatilityFree cash flow has been uneven with a notable dip in FY2022 and softer growth in FY2024–FY2025 before rebounding. That volatility reduces predictability for dividends, buybacks or acquisitions and complicates multi-year capital allocation despite generally positive cash generation.
Uneven Revenue GrowthRevenue shows cyclicality or timing sensitivity—muted FY2025 followed by a strong FY2026 step-up—suggesting dependence on project wins, customer qualification timing or end-market cycles. Such unevenness complicates forecasting and makes sustainable margin leverage harder to predict.
Advanced Enzyme Technologies Ltd News
ADVENZYMES FAQ
What was Advanced Enzyme Technologies Ltd’s price range in the past 12 months?
Advanced Enzyme Technologies Ltd lowest stock price was ₹251.90 and its highest was ₹419.80 in the past 12 months.
What is Advanced Enzyme Technologies Ltd’s market cap?
Advanced Enzyme Technologies Ltd’s market cap is ₹33.01B.
When is Advanced Enzyme Technologies Ltd’s upcoming earnings report date?
Advanced Enzyme Technologies Ltd’s upcoming earnings report date is Nov 06, 2026 which is in 64 days.
How were Advanced Enzyme Technologies Ltd’s earnings last quarter?
Advanced Enzyme Technologies Ltd released its earnings results on Aug 08, 2026. The company reported ₹3.313 earnings per share for the quarter.
Is Advanced Enzyme Technologies Ltd overvalued?
According to Wall Street analysts Advanced Enzyme Technologies Ltd’s price is currently Overvalued.
Does Advanced Enzyme Technologies Ltd pay dividends?
Advanced Enzyme Technologies Ltd pays a Quarterly dividend of ₹1.35 which represents an annual dividend yield of 0.46%. See more information on Advanced Enzyme Technologies Ltd dividends here
What is Advanced Enzyme Technologies Ltd’s EPS estimate?
Advanced Enzyme Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Advanced Enzyme Technologies Ltd have?
Advanced Enzyme Technologies Ltd has 111,976,150 shares outstanding.
What happened to Advanced Enzyme Technologies Ltd’s price movement after its last earnings report?
Advanced Enzyme Technologies Ltd reported an EPS of ₹3.313 in its last earnings report. Following the earnings report the stock price went up 6.825%.
Which hedge fund is a major shareholder of Advanced Enzyme Technologies Ltd?
Currently, no hedge funds are holding shares in IN:ADVENZYMES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Limited, headquartered in Thane, India, is a global company engaged in the research, development, manufacturing, and marketing of enzymes and probiotics. Its operations span India, the United States, Asia, and Europe. The company's diverse enzyme offerings cater to human healthcare, animal nutrition, and an extensive range of food processing sectors, including fruit and vegetable, baking, brewing, malting, grain, protein modification, yeast, dairy, and oils/fats processing, as well as various specialty applications. Beyond food-related uses, it also supplies industrial enzymes for non-food industries like textile processing, leather, pulp and paper production, detergents and cleaning aids, biofuels, and biocatalysis. Founded in 1957, the company was previously known as Advanced Biochemicals Limited before changing its name to Advanced Enzyme Technologies Limited in 2005.
Technical Analysis
AVT Natural Products Limited
―
Jubilant Ingrevia Ltd.
―
Neogen Chemicals Ltd.
―
Rossari Biotech Ltd
―
Vidhi Specialty Food Ingredients Ltd
―